Aion Therapeutic ANTCF Stock
Aion Therapeutic Price Chart
Aion Therapeutic ANTCF Financial and Trading Overview
| Aion Therapeutic stock price | 0.0020 USD |
| Previous Close | 0.002 USD |
| Open | 0.002 USD |
| Bid | 0.002 USD x 0 |
| Ask | 0.02 USD x 0 |
| Day's Range | 0.002 - 0.002 USD |
| 52 Week Range | 0.0013 - 0.02 USD |
| Volume | 15K USD |
| Avg. Volume | 3.04K USD |
| Market Cap | 1.26M USD |
| Beta (5Y Monthly) | -0.5 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ANTCF Valuation Measures
| Enterprise Value | 3.79M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.8528209 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 2.573 |
| Enterprise Value/EBITDA | -2.537 |
Trading Information
Aion Therapeutic Stock Price History
| Beta (5Y Monthly) | -0.5 |
| 52-Week Change | -50.00000000000000000000000000000000% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.02 USD |
| 52 Week Low | 0.0013 USD |
| 50-Day Moving Average | 0.002 USD |
| 200-Day Moving Average | 0.003199 USD |
ANTCF Share Statistics
| Avg. Volume (3 month) | 3.04K USD |
| Avg. Daily Volume (10-Days) | 3.33K USD |
| Shares Outstanding | 497.15M |
| Float | 452.15M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | April 30, 2024 |
| Most Recent Quarter (mrq) | January 31, 2025 |
| Next Fiscal Year End | April 30, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -43.12% |
| Gross Margin | 32.28% |
| EBITDA Margin | -101.42% |
Management Effectiveness
| Return on Assets (ttm) | -26.85% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.47M USD |
| Revenue Per Share (ttm) | 0.003 USD |
| Quarterly Revenue Growth (yoy) | 145.40% |
| Gross Profit (ttm) | 475.59K USD |
| EBITDA | -1493947 USD |
| Net Income Avi to Common (ttm) | -6645391 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.82K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 2.81M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.191 |
| Book Value Per Share (mrq) | -0.00650034 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1545793 USD |
| Levered Free Cash Flow (ttm) | -1359159 USD |
Profile of Aion Therapeutic
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 700 West Georgia Street |
| ZIP | V7Y 1K8 |
| Phone | 416 460 3000 |
| Website | N/A |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Aion Therapeutic Inc. engages in the health and wellness business in the United States. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was incorporated in 2011 and is based in Vancouver, Canada.
Q&A For Aion Therapeutic Stock
What is a current ANTCF stock price?
Aion Therapeutic ANTCF stock price today per share is 0.0020 USD.
How to purchase Aion Therapeutic stock?
You can buy ANTCF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aion Therapeutic?
The stock symbol or ticker of Aion Therapeutic is ANTCF.
Which industry does the Aion Therapeutic company belong to?
The Aion Therapeutic industry is Drug Manufacturers - Specialty & Generic.
How many shares does Aion Therapeutic have in circulation?
The max supply of Aion Therapeutic shares is 628.06M.
What is Aion Therapeutic Price to Earnings Ratio (PE Ratio)?
Aion Therapeutic PE Ratio is now.
What was Aion Therapeutic earnings per share over the trailing 12 months (TTM)?
Aion Therapeutic EPS is -0.01 USD over the trailing 12 months.
Which sector does the Aion Therapeutic company belong to?
The Aion Therapeutic sector is Healthcare.


